Expression and effects of inhibition of type I insulin-like growth factor receptor tyrosine kinase in mantle cell lymphoma

Haematologica ◽

10.3324/haematol.2010.031567 ◽

2011 ◽

Vol 96 (6) ◽

pp. 871-880 ◽

Author(s):

D. Vishwamitra ◽

P. Shi ◽

D. Wilson ◽

R. Manshouri ◽

F. Vega ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Mantle Cell Lymphoma ◽

Receptor Tyrosine Kinase ◽

Cell Lymphoma ◽

Growth Factor Receptor ◽

Type I ◽

Insulin Like Growth Factor ◽

Download Full-text

Inhibition of type I insulin-like growth factor receptor tyrosine kinase by picropodophyllin induces apoptosis and cell cycle arrest in T lymphoblastic leukemia/lymphoma

Leukemia & Lymphoma ◽

10.3109/10428194.2013.862241 ◽

2014 ◽

Vol 55 (8) ◽

pp. 1876-1883 ◽

Author(s):

Zhiwei Huang ◽

Zhijia Fang ◽

Hong Zhen ◽

Li Zhou ◽

Hesham M. Amin ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Cell Cycle Arrest ◽

Receptor Tyrosine Kinase ◽

Lymphoblastic Leukemia ◽

Growth Factor Receptor ◽

Type I ◽

Insulin Like Growth Factor ◽

Download Full-text

Increased tumor cell proliferation in mantle cell lymphoma is associated with elevated insulin-like growth factor 2 mRNA-binding protein 3 expression

Modern Pathology ◽

10.1038/modpathol.2012.84 ◽

2012 ◽

Vol 25 (9) ◽

pp. 1227-1235 ◽

Author(s):

Elena M Hartmann ◽

Sílvia Beà ◽

Alba Navarro ◽

Vanessa Trapp ◽

Elías Campo ◽

...

Keyword(s):

Cell Proliferation ◽

Growth Factor ◽

Mantle Cell Lymphoma ◽

Cell Lymphoma ◽

Insulin Like Growth Factor ◽

Tumor Cell Proliferation ◽

Mrna Binding Protein ◽

Mantle Cell ◽

Download Full-text

mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR

Cell Research ◽

10.1038/cr.2015.133 ◽

2015 ◽

Vol 26 (1) ◽

pp. 46-65 ◽

Author(s):

Yancun Yin ◽

Hui Hua ◽

Minjing Li ◽

Shu Liu ◽

Qingbin Kong ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Insulin Receptor ◽

Kinase Activity ◽

Growth Factor Receptor ◽

Receptor Activation ◽

Type I ◽

Insulin Like Growth Factor ◽

Tyrosine Kinase Activity

Download Full-text

Faculty Opinions recommendation of mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725949975.793554255 ◽

2018 ◽

Author(s):

Joseph Avruch

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Insulin Receptor ◽

Kinase Activity ◽

Growth Factor Receptor ◽

Receptor Activation ◽

Type I ◽

Insulin Like Growth Factor ◽

Tyrosine Kinase Activity

Download Full-text

Faculty Opinions recommendation of mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725949975.793516541 ◽

2016 ◽

Author(s):

Bruce Veit

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Insulin Receptor ◽

Kinase Activity ◽

Growth Factor Receptor ◽

Receptor Activation ◽

Type I ◽

Insulin Like Growth Factor ◽

Tyrosine Kinase Activity

Download Full-text

OR10,55 GSK-3beta regulates insulin-like growth factor receptor tyrosine kinase activity by phosphorylation of S1248 in the C-terminus

Growth Hormone & IGF Research ◽

10.1016/s1096-6374(10)70069-1 ◽

2010 ◽

Vol 20 ◽

pp. S25

Author(s):

G.M. Kelly ◽

D.A. Buckley ◽

P.A. Kiely ◽

R. O'Connor

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Receptor Tyrosine Kinase ◽

Kinase Activity ◽

Growth Factor Receptor ◽

Insulin Like Growth Factor ◽

Tyrosine Kinase Activity ◽

Download Full-text

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

10.32388/jfobd7 ◽

2020 ◽

Author(s):

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Epidermal Growth

Download Full-text

Insulin-like growth factor receptor type I as a target for cancer therapy

Frontiers in Bioscience ◽

10.2741/s382 ◽

2013 ◽

Vol S5 (2) ◽

pp. 439-450 ◽

Author(s):

Nathalie Corvaia

Keyword(s):

Growth Factor ◽

Cancer Therapy ◽

Growth Factor Receptor ◽

Receptor Type ◽

Type I ◽

Insulin Like Growth Factor

Download Full-text

Faculty Opinions recommendation of Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718073986.793497271 ◽

2014 ◽

Author(s):

Stephan Stilgenbauer

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Mantle Cell Lymphoma ◽

Peripheral Blood ◽

Kinase Inhibitor ◽

Cell Lymphoma ◽

Mantle Cell ◽

Bruton Tyrosine Kinase

Download Full-text

Association between E-cadherin and sensitivity of hepatocellular carcinoma to treatment with epidermal growth factor receptor tyrosine kinase inhibitor

Academic Journal of Second Military Medical University ◽

10.3724/sp.j.1008.2014.00915 ◽

2014 ◽

Vol 35 (8) ◽

pp. 915

Author(s):

Rong-chun XING ◽

Jun ZHENG ◽

Ping CHEN ◽

Wei-hong ZHENG ◽

Wei LIU ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth

Download Full-text